← Evidence map

ArticleDermatology and therapy2026

Bimekizumab Impact on Patient-Reported Outcomes in Plaque Psoriasis: 4-Year Results from BE SURE, BE VIVID, BE READY, and BE BRIGHT.

April Armstrong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

4 trials

NCT03370133phase 3567 enrolled2017 NCT03410992phase 3435 enrolled2018 NCT03412747phase 3478 enrolled2018 NCT03598790phase 31,353 enrolled2018

Bimekizumab Impact on Patient-Reported Outcomes in Plaque Psoriasis: 4-Year Results from BE SURE, BE VIVID, BE READY, and BE BRIGHT. | OpenQuestion